Contact
Please use this form to send email to PR contact of this press release:
Atea Pharmaceuticals Announces First Patient Dosed in Phase 2 Virology Trial of AT-527 in Outpatient Setting
TO:
Please use this form to send email to PR contact of this press release:
Atea Pharmaceuticals Announces First Patient Dosed in Phase 2 Virology Trial of AT-527 in Outpatient Setting
TO: